Alnylam Pharmaceuticals
ALNY
#757
Rank
$33.12 B
Marketcap
$247.56
Share price
0.43%
Change (1 day)
-45.52%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company